Dowling & Yahnke LLC Dexcom Inc Transaction History

Dowling & Yahnke LLC

$215 Million
Q3 2022

A detailed history of Dowling & Yahnke LLC transactions in Dexcom Inc stock. As of the latest transaction made, Dowling & Yahnke LLC holds 59,056 shares of DXCM stock, worth $4.48 Million. This represents 2.21% of its overall portfolio holdings.

Number of Shares

59,056

Previous 58,968 0.15%

Holding current value

$4.48 Million

Previous $4.4 Million 8.21%

% of portfolio

2.21%

Previous 0.21%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	BUY	$76.35 - $94.18 $6,718 - $8,287	88 Added 0.15%	59,056 $4.76 Million
Q2 2022 Aug 10, 2022	BUY	$67.99 - $132.89 $3.14 Million - $6.15 Million	46,250 Added 363.66%	58,968 $4.4 Million
Q1 2022 May 04, 2022	SELL	$94.08 - $130.2 $120,140 - $166,265	-1,277 Reduced 9.12%	12,718 $6.51 Million
Q4 2021 Feb 10, 2022	BUY	$129.87 - $162.82 $4,935 - $6,187	38 Added 0.27%	13,995 $7.52 Million
Q3 2021 Nov 12, 2021	BUY	$106.71 - $143.18 $1,387 - $1,861	13 Added 0.09%	13,957 $7.63 Million
Q2 2021 Jul 21, 2021	BUY	$80.99 - $107.93 $65,277 - $86,991	806 Added 6.13%	13,944 $5.95 Million
Q1 2021 Apr 29, 2021	BUY	$84.79 - $104.74 $763 - $942	9 Added 0.07%	13,138 $4.72 Million
Q4 2020 Jan 28, 2021	BUY	$78.0 - $104.5 $624 - $836	8 Added 0.06%	13,129 $4.85 Million
Q3 2020 Oct 19, 2020	SELL	$95.51 - $112.95 $3.25 Million - $3.84 Million	-34,000 Reduced 72.15%	13,121 $5.41 Million
Q2 2020 Jul 31, 2020	BUY	$62.68 - $105.34 $44,878 - $75,423	716 Added 1.54%	47,121 $19.1 Million
Q1 2020 May 15, 2020	SELL	$47.79 - $75.63 $119,666 - $189,377	-2,504 Reduced 5.12%	46,405 $12.5 Million
Q4 2019 Jan 27, 2020	SELL	$36.62 - $57.29 $91,403 - $142,995	-2,496 Reduced 4.86%	48,909 $10.7 Million
Q3 2019 Oct 29, 2019	SELL	$35.53 - $43.8 $88,825 - $109,500	-2,500 Reduced 4.64%	51,405 $7.67 Million
Q2 2019 Jul 22, 2019	BUY	$27.84 - $38.92 $26,420 - $36,935	949 Added 1.79%	53,905 $8.08 Million
Q1 2019 Apr 30, 2019	SELL	$28.07 - $38.18 $70,175 - $95,450	-2,500 Reduced 4.51%	52,956 $6.31 Million
Q4 2018 Jan 24, 2019	SELL	$26.99 - $37.37 $67,475 - $93,425	-2,500 Reduced 4.31%	55,456 $7.19 Million
Q3 2018 Oct 30, 2018	SELL	$23.35 - $36.72 $114,391 - $179,891	-4,899 Reduced 7.79%	57,956 $8.29 Million
Q2 2018 Jul 30, 2018	BUY	$17.54 - $25.22 $76,351 - $109,782	4,353 Added 7.44%	62,855 $5.97 Million
Q4 2017 Feb 02, 2018	BUY	$11.12 - $15.38 $389,200 - $538,300	35,000 Added 148.92%	58,502 $3.36 Million
Q3 2017 Nov 08, 2017	BUY	$11.36 - $18.98 $266,982 - $446,067	23,502	23,502 $1.15 Million

Others Institutions Holding DXCM

# of Institutions

1,013

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $29.3B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dowling & Yahnke LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dowling & Yahnke LLC with notifications on news.

Account

Dowling & Yahnke LLC Dexcom Inc Transaction History